Janssen Pharmaceutical K.k.
Clinical trials sponsored by Janssen Pharmaceutical K.k., explained in plain language.
-
New hope for stubborn lung infection: bedaquiline combo shows promise
Disease control CompletedThis study tested whether adding the drug bedaquiline to standard antibiotics (clarithromycin and ethambutol) helps clear a stubborn lung infection called MAC lung disease. About 129 adults with infection that didn't respond to prior treatment took part. The main goal was to see …
Phase: PHASE2, PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated May 01, 2026 20:11 UTC
-
New hope for kids with high blood pressure in the lungs
Disease control CompletedThis study tested a medicine called macitentan in 7 Japanese children aged 3 months to 15 years who have pulmonary arterial hypertension, a rare condition where blood pressure in the lungs is too high. The goal was to see if the drug improves blood flow through the lungs after 24…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug shows promise in taming Crohn's Flare-Ups
Disease control CompletedThis study tested the safety of a drug called guselkumab in 38 adults with moderate to severe Crohn's disease, a chronic inflammatory bowel condition. Participants received the drug and were monitored for side effects and disease activity over 48 weeks. The goal was to see if gus…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Japanese skin condition study reveals Real-World treatment trends
Knowledge-focused CompletedThis study looked at 276 people in Japan with palmoplantar pustulosis (PPP), a skin condition causing blisters on hands and feet. Researchers tracked which treatments patients used and how long they stayed on them. The goal was to understand current treatment patterns, not to tes…
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Japanese registry reveals how men fare with advanced prostate cancer in daily practice
Knowledge-focused CompletedThis study followed nearly 1,000 Japanese men with high-risk prostate cancer that had spread but had not yet received hormone therapy. Researchers tracked how well treatments worked in real-world settings, including PSA levels, survival, and quality of life. The goal was to gathe…
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC